Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4142647

CC(C)N(C(=O)Nc1c[nH]nc1-c1nc2cc(F)c(N3CCN(C)CC3)cc2[nH]1)C(C)C.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.40
KDR P35968 4/20 0.40
FGFR2 P21802 3/20 0.40
FGFR3 P22607 3/20 0.40
SRPK1 Q96SB4 1/20 0.39
OPRL1 P41146 2/20 0.35
KDM4E B2RXH2 1/20 0.34
WHR1 P49842 2/20 0.34
ITK Q08881 2/20 0.33
TEK Q02763 1/20 0.33
BMPR1A P36894 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVRL1 P37023 1/20 0.33
ACVR1 Q04771 1/20 0.33
SYK P43405 1/20 0.33
TNKS O95271 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
FLT3 P36888 1/20 0.32
CXCR3 P49682 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4129282 0.95 FGFR1 (0.43) FGFR1KDRFGFR2FGFR3SRPK1
SCHEMBL4124997 0.92 FGFR1 (0.41) FGFR1KDRFGFR2FGFR3SRPK1
Trifluoroacetic Acid SCHEMBL4130010 0.89 SYK (0.43) FGFR1KDRFGFR2FGFR3SRPK1
SCHEMBL4130131 0.87 FGFR1 (0.43) FGFR1KDRFGFR2FGFR3ITK
Trifluoroacetic Acid SCHEMBL4138498 0.86 SYK (0.41) FGFR1KDRFGFR2FGFR3SRPK1
Trifluoroacetic Acid SCHEMBL4127209 0.85 FGFR1 (0.39) FGFR1KDRFGFR2FGFR3SRPK1
SCHEMBL4134571 0.84 FGFR1 (0.41) FGFR1KDRFGFR2FGFR3ITK
SCHEMBL3928874 0.84 SYK (0.46) FGFR1KDRFGFR2FGFR3SRPK1
Trifluoroacetic Acid SCHEMBL4133711 0.83 FGFR1 (0.38) FGFR1KDRFGFR2FGFR3SRPK1
Trifluoroacetic Acid SCHEMBL4130036 0.81 ITK (0.42) FGFR1KDRFGFR2FGFR3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9126969-B2 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof AVENTIS PHARMA S.A. (FR) 2015-09-08 US disclosed
US-20090197866-A1 PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197866-A1 PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF RB1, CCNI, CDK2 FGFR1 2171/4885KDR 1051/4885FGFR2 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.